Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Organize PDUFA V Patient-Focused Meetings Around Disease Clusters, Advocates Say

Executive Summary

Patient groups urge FDA not to limit 20 meetings over the next five years to specific diseases, as the agency has proposed, but instead to take a broader view on diseases based upon similar characteristics, quality-of-life burden and available treatment options.


Related Content

Chronic Fatigue Syndrome Drug Development Efforts Get A Boost From FDA
Gastroenterology Endpoints To Get Four-Day Series Of FDA Workshops
Disease-Of-The-Quarter Club: FDA Plans 20 Patient Network Meetings Over Five Years





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts